JULIAN ADAMS Insider Trading $INFI INFINITY PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JULIAN ADAMS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JULIAN ADAMS. JULIAN ADAMS is Chief Scientific Officer in INFINITY PHARMACEUTICALS, INC. ($INFI) and President in INFINITY PHARMACEUTICALS, INC. ($INFI) and President of R&D in INFINITY PHARMACEUTICALS, INC. ($INFI) and President of R&D and CSO in INFINITY PHARMACEUTICALS, INC. ($INFI) and President, R&D & CSO in INFINITY PHARMACEUTICALS, INC. ($INFI) and Director in PIERIS PHARMACEUTICALS, INC. ($PIRS).
JULIAN ADAMS in INFINITY PHARMACEUTICALS, INC.
Trading Symbol: INFIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JULIAN ADAMS: President of R&D and CSO, Chief Scientific Officer, President, R&D & CSO, President
Holdings: 59,150 shares
Current Value: $139,003
Latest Transaction: Nov 02 2016
$INFI Market Capitalization: $115.87M
$INFI Previous Close: $2.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JULIAN ADAMS in INFINITY PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 02 2016 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President of R&D | Grant | A | 0.00 | 59,150 | 0 | 59,150 | 0 to 59.2 K |
Jan 08 2016 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President of R&D | Option Exercise | A | 6.71 | 80,000 | 536,800 | 80,000 | |
Jan 16 2015 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President of R&D | Option Exercise | A | 15.74 | 125,000 | 1,967,500 | 125,000 | |
Jan 14 2014 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President of R&D | Option Exercise | A | 12.91 | 56,900 | 734,579 | 56,900 | |
Jan 08 2013 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President of R&D | Option Exercise | A | 36.85 | 101,780 | 3,750,593 | 101,780 | |
Jan 09 2012 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President of R&D | Option Exercise | A | 7.93 | 126,850 | 1,005,921 | 126,850 | |
Jan 07 2011 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President of R&D | Option Exercise | A | 5.94 | 106,210 | 630,887 | 106,210 | |
Jan 07 2010 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President of R&D an ... | Option Exercise | A | 6.25 | 104,000 | 650,000 | 104,000 | |
Jan 07 2009 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President of R&D an ... | Option Exercise | A | 7.27 | 50,000 | 363,500 | 50,000 | |
Dec 08 2008 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | Chief Scientific Of ... | Option Exercise | A | 7.18 | 110,000 | 789,800 | 110,000 | |
Oct 30 2008 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President, R&D & CS ... | Option Exercise | M | 3.48 | 27,628 | 96,145 | 0 | |
Oct 30 2008 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President, R&D & CS ... | Option Exercise | M | 3.48 | 331 | 1,152 | 0 | |
Oct 30 2008 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President, R&D & CS ... | Option Exercise | M | 2.04 | 54,727 | 111,643 | 0 | |
Oct 30 2008 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President, R&D & CS ... | Option Exercise | M | 2.04 | 54,727 | 111,643 | 0 | |
Oct 30 2008 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President, R&D & CS ... | Buy | M | 3.48 | 27,628 | 96,145 | 262,943 | 235.3 K to 262.9 K (+11.74 %) |
Oct 30 2008 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President, R&D & CS ... | Buy | M | 3.48 | 331 | 1,152 | 235,315 | 235 K to 235.3 K (+0.14 %) |
Oct 30 2008 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President, R&D & CS ... | Buy | M | 2.04 | 54,727 | 111,643 | 234,984 | 180.3 K to 235 K (+30.36 %) |
Oct 30 2008 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President, R&D & CS ... | Buy | M | 2.04 | 54,727 | 111,643 | 180,257 | 125.5 K to 180.3 K (+43.60 %) |
Dec 14 2007 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President, R&D & CS ... | Option Exercise | A | 9.80 | 111,200 | 1,089,760 | 111,200 | |
Jan 29 2007 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President | Option Exercise | A | 13.59 | 200,000 | 2,718,000 | 200,000 | |
Sep 13 2006 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President | Option Exercise | A | 3.48 | 27,628 | 96,145 | 27,628 | |
Sep 13 2006 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President | Option Exercise | A | 3.48 | 331 | 1,152 | 331 | |
Sep 13 2006 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President | Option Exercise | A | 2.04 | 54,727 | 111,643 | 54,727 | |
Sep 13 2006 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President | Option Exercise | A | 2.04 | 54,727 | 111,643 | 54,727 | |
Sep 13 2006 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President | Grant | A | 0.00 | 125,530 | 0 | 125,530 | 0 to 125.5 K |
Page: 1